TPST Receives Nasdaq Deficiency Notice, Fails to Meet $2.5M Stockholders' Equity Requirement, Non-Compliant with Independent Director Rules
Tempest Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $1.45
-7.0% in 3d after detection
Post-detection moves
1h
—
1d
-4.8%
3d
-7.0%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS